Opinion: Academic Publishing Is Broken

The current system by which academics publish their scientific discoveries is a massive waste of money.

Written byMichael P. Taylor
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

FLICKR, DULLHUNK

Academic publishers are currently up in arms about the Federal Research Public Access Act (FRPAA)—a bill that has the perfectly reasonable goal of making publicly funded research available to the public that funded it. Tom Allen, president of the American Association of Publishers, described it rather hysterically as “intellectual eminent domain, but without fair compensation.” Why are he and his colleagues so desperate to retain the current business model?

By any objective standard, academic publishing is a very strange business indeed. It became established at a time when all publishing was on paper, when duplication and delivery were demanding problems, and when publishers provided an important service to researchers. Now, as the Internet is dramatically changing other forms of publishing, academic journals seem stuck in ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies